Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Patients Experience of Living with Cancer Associated Thrombosis in France (LE PELICAN)

Isabelle Mahe, MD PhD, Annmarie Nelson, PhD, Jean Chidiac, MD, Parinata Swarnkar, Mickael Pinson, Michele Pinson, Simon Noble, MDFRCP,MBBS

Blood (2019) 134 (Supplement_1): 3684.

https://doi.org/10.1182/blood-2019-123210

Published: 2019

Journal Articles

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Isabelle Mahe, MD PhD, Jean Chidiac, MD, Sadji Djennaoui, MD, Nicolas Javaud, MD PhD, Benjamin Planquette, MD PhD, Edith Peynaud-Debayle, MD, Laurent Sofiane Baccar, MD, Bénédicte Dumont, PhD, Guy Meyer, Geneviève Contant, PhD, Francois Depasse, PharmD, Virginie Siguret, PhD, Hélène Helfer, PhD

Blood (2019) 134 (Supplement_1): 3663.

https://doi.org/10.1182/blood-2019-124973

Published: 2019

Journal Articles

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Isabelle Mahe, MD PhD, Ludovic Plaisance, MD, Céline Chapelle, Silvy Laporte, MS, PhD, Benjamin Planquette, MD PhD, Laurent Bertoletti, MD PhD, Jean Chidiac, MD, Francis Couturaud, MD PhD, Lionel Falchiero, MD, Nicolas Falvo, MD, Isild Mahé, Hélène Helfer, PhD, Guy Meyer

Blood (2019) 134 (Supplement_1): 3664.

https://doi.org/10.1182/blood-2019-124745

Published: 2019

Journal Articles

Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells.

Remi Varin, Shahsultan Mirshahi, Pehzman Mirshahi, Jean Chidiac, Gerald Kierzek, Jean-Pierre Marie, Massoud Mirshahi, Claudine Soria, Jeannette Soria

Blood (2009) 114 (22): 1064.

https://doi.org/10.1182/blood.V114.22.1064.1064

Published: 2009

Journal Articles

A Novel Mechanism of Action of Rivaroxaban: Inhibition of Monocyte and Macrophage Procoagulant Activity and Consequence On Inflammatory Process.

Marc Laurent, Remi Varin, Ulrich Joimel, Hong Li, He Lu, Emmanuel Blot, Shahsultan Mirshahi, Lionel Cazin, Jean Chidiac, Jean-Pierre Marie, MD, Jeannette Soria, Claudine Soria

Blood (2009) 114 (22): 3124.

https://doi.org/10.1182/blood.V114.22.3124.3124

Published: 2009

NARROW

Patients Experience of Living with Cancer Associated Thrombosis in France (LE PELICAN)

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells.

A Novel Mechanism of Action of Rivaroxaban: Inhibition of Monocyte and Macrophage Procoagulant Activity and Consequence On Inflammatory Process.

Email alerts

ASH Publications

American Society of Hematology

Patients Experience of Living with Cancer Associated Thrombosis in France (LE PELICAN)

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells.

A Novel Mechanism of Action of Rivaroxaban: Inhibition of Monocyte and Macrophage Procoagulant Activity and Consequence On Inflammatory Process.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only